menu
    • menu

    Company profile for F. Hoffmann-La Roche

    NEW Drugs in Dev: 295
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are known for pharmaceutical medicines since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally. Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healt...
    We are known for pharmaceutical medicines since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally. Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    F. Hoffmann-La RocheSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Konzern-Hauptsitz Grenzacherstrasse 124 CH-4070 Basel
    Telephone
    Telephone
    +41-61-688 1111
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.roche.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roche Seeks Partner to Take Over Plant, Produce Key Antibiotic
    Roche Seeks Partner to Take Over Plant, Produce Key Antibiotic

    23 Feb 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/amid-eu-generics-woes-roche-looks-divest-its-former-blockbuster-antibiotic

    FIERCE PHARMA
    23 Feb 2026
    Share Share
    FDA Approves Venclexta, Acalabrutinib For Untreated CLL Leukemia
    FDA Approves Venclexta, Acalabrutinib For Untreated CLL Leukemia

    23 Feb 2026

    // PRESS RELEASE

    https://news.abbvie.com/2026-02-20-U-S-Food-and-Drug-Administration-FDA-Approves-Combination-Treatment-of-VENCLEXTA-R-venetoclax-and-Acalabrutinib-for-Previously-Untreated-Patients-With-Chronic-Lymphocytic-Leukemia-CLL

    PRESS RELEASE
    23 Feb 2026
    Share Share
    FDA accepts NDA for Roche’s giredestrant in ESR1-Mutated
    FDA accepts NDA for Roche’s giredestrant in ESR1-Mutated

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/20/3241682/0/en/FDA-accepts-New-Drug-Application-for-Roche-s-giredestrant-in-ESR1-mutated-ER-positive-advanced-breast-cancer.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Roche Announces Positive Phase III Results For Gazyva/Gazyvaro
    Roche Announces Positive Phase III Results For Gazyva/Gazyvaro

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/16/3238524/0/en/Roche-announces-positive-phase-III-results-for-Gazyva-Gazyvaro-in-primary-membranous-nephropathy-marking-a-significant-milestone-in-this-autoimmune-disease.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Roche Announces Changes to Enlarged Executive Committee
    Roche Announces Changes to Enlarged Executive Committee

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3238932/0/en/Change-to-the-Roche-Enlarged-Corporate-Executive-Committee.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Roche Unveils Data Behind BTK Inhibitor's Phase 3 MS Win
    Roche Unveils Data Behind BTK Inhibitor's Phase 3 MS Win

    09 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/roche-unveils-data-behind-btk-inhibitors-phase-3-multiple-sclerosis-win

    FIERCE BIOTECH
    09 Feb 2026
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Ceftriaxone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Ceftriaxone

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13656

    Submission : 1998-09-01

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2001-084 - Rev 01

    Issue Date : 2008-05-06

    Type : Chemical

    Substance Number : 991

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Digoxin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Digoxin

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 2277

    Submission : 1974-05-17

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1996-048 - Rev 02

    Issue Date : 2006-11-10

    Type : Chemical

    Substance Number : 79

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Vitamin D3

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Vitamin D3

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 2373

    Submission : 1974-12-13

    Status : Inactive

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 218MF10105

    Registrant's Address : Grenzacherstrasse 124, 4070 Basel, Switzerland

    Initial Date of Registration : 2006-01-30

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Alpha-D-Galactose

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Alpha-D-Galactose

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 8650

    Submission : 1990-07-03

    Status : Inactive

    Type : II

     CEP/COS Inactive-api
    ✖

    Certificate Number : R1-CEP 1997-098 - Rev 02

    Issue Date : 2010-12-01

    Type : Chemical

    Substance Number : 1215

    Status : Withdrawn by Holder

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Bezafibrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Bezafibrate

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1998-124 - Rev 04

    Issue Date : 2010-11-26

    Type : Chemical

    Substance Number : 1394

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Carvedilol

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Carvedilol

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2002-001 - Rev 03

    Issue Date : 2012-07-25

    Type : Chemical

    Substance Number : 1745

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Doxepin Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Doxepin Hydrochloride

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1999-094 - Rev 01

    Issue Date : 2008-07-21

    Type : Chemical

    Substance Number : 1096

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Sucralfate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Sucralfate

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 3542

    Submission : 1979-06-12

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Sulfadoxine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Sulfadoxine

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2000-066 - Rev 04

    Issue Date : 2015-09-24

    Type : Chemical

    Substance Number : 740

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Torsemide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Torsemide

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2005-210 - Rev 00

    Issue Date : 2011-09-30

    Type : Chemical

    Substance Number : 2132

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Bezafibrate

    CEP/COS

    International Sweetener Colloquium
    Not Confirmed
    arrow

    02

    Carvedilol

    CEP/COS

    International Sweetener Colloquium
    Not Confirmed
    arrow

    03

    Ceftriaxone sodium, Sterile

    CEP/COS

    International Sweetener Colloquium
    Not Confirmed
    arrow

    04

    Digitoxin

    CEP/COS

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Digitoxin

    Germany
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Roche Diagnostics GmbH

    Certificate Numbers : R1-CEP 1997-085 - Rev 01

    Status : Withdrawn by Holder

    Issue Date : 2005-06-23

    Type : Chemical

    Substance Number : 78

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Digoxin

    CEP/COS

    International Sweetener Colloquium
    Not Confirmed
    arrow

    06

    Doxepin hydrochloride

    CEP/COS

    International Sweetener Colloquium
    Not Confirmed
    arrow

    07

    Galactose

    CEP/COS

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Galactose

    Germany
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Roche Diagnostics GmbH

    Certificate Numbers : R1-CEP 1997-098 - Rev 02

    Status : Withdrawn by Holder

    Issue Date : 2010-12-01

    Type : Chemical

    Substance Number : 1215

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Glibenclamide

    CEP/COS

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Glibenclamide

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    F. Hoffmann-La Roche

    Certificate Numbers : R1-CEP 1999-003 - Rev 01

    Status : Withdrawn by Holder

    Issue Date : 2009-11-19

    Type : Chemical

    Substance Number : 718

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Isotretinoin

    CEP/COS

    International Sweetener Colloquium
    Not Confirmed
    arrow

    Isotretinoin

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    F. Hoffmann-La Roche

    Certificate Numbers : R1-CEP 2002-034 - Rev 01

    Status : Withdrawn by Holder

    Issue Date : 2008-11-25

    Type : Chemical

    Substance Number : 1019

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Sulfadoxine

    CEP/COS

    International Sweetener Colloquium
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Pa...

    Details:

    Inavolisib is a small molecule drug, which is currently being evaluated in Phase II clinical studies for the treatment of breast neoplasms.


    Lead Product(s): Inavolisib,Ribociclib,Fulvestrant

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable February 12, 2026

    blank

    01

    F. Hoffmann-La Roche

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    F. Hoffmann-La Roche

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Inavolisib,Ribociclib,Fulvestrant

    Therapeutic Area : Oncology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant...

    Details : Inavolisib is a small molecule drug, which is currently being evaluated in Phase II clinical studies for the treatment of breast neoplasms.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    February 12, 2026

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

    Details:

    YL201 is a antibody-drug conjugate, which is currently being evaluated in Phase I/ Phase II clinical studies for the treatment of thoracic neoplasms.


    Lead Product(s): YL201,Atezolizumab

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase I/ Phase IIProduct Type: Antibody-drug Conjugate

    Recipient: MediLink Therapeutics

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable February 12, 2026

    blank

    02

    Genentech

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Genentech

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : YL201,Atezolizumab

    Therapeutic Area : Oncology

    Highest Development Status : Phase I/ Phase II

    Recipient : MediLink Therapeutics

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid T...

    Details : YL201 is a antibody-drug conjugate, which is currently being evaluated in Phase I/ Phase II clinical studies for the treatment of thoracic neoplasms.

    Product Name : Undisclosed

    Product Type : Antibody-drug Conjugate

    Upfront Cash : Inapplicable

    February 12, 2026

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material

    Details:

    Vabysmo (Faricimab) is a antibody drug, which is currently being evaluated in Phase IV clinical studies for the treatment of macular degeneration.


    Lead Product(s): Faricimab

    Therapeutic Area: Ophthalmology Brand Name: Vabysmo

    Study Phase: Phase IVProduct Type: Antibody, Unconjugated

    Recipient: Biobizkaia Health Research Institute

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable February 11, 2026

    blank

    03

    F. Hoffmann-La Roche

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    F. Hoffmann-La Roche

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Faricimab

    Therapeutic Area : Ophthalmology

    Highest Development Status : Phase IV

    Recipient : Biobizkaia Health Research Institute

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material

    Details : Vabysmo (Faricimab) is a antibody drug, which is currently being evaluated in Phase IV clinical studies for the treatment of macular degeneration.

    Product Name : Vabysmo

    Product Type : Antibody, Unconjugated

    Upfront Cash : Inapplicable

    February 11, 2026

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell Lymphomas

    Details:

    Glofitamab is a antibody drug, which is currently being evaluated in Phase II clinical studies for the treatment of lymphoma, large b-cell, diffuse.


    Lead Product(s): Glofitamab

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Antibody, Unconjugated

    Recipient: American University of Beirut Medical Center

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable February 04, 2026

    blank

    04

    F. Hoffmann-La Roche

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    F. Hoffmann-La Roche

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Glofitamab

    Therapeutic Area : Oncology

    Highest Development Status : Phase II

    Recipient : American University of Beirut Medical Center

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients Wi...

    Details : Glofitamab is a antibody drug, which is currently being evaluated in Phase II clinical studies for the treatment of lymphoma, large b-cell, diffuse.

    Product Name : Undisclosed

    Product Type : Antibody, Unconjugated

    Upfront Cash : Inapplicable

    February 04, 2026

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    SanegeneBio Partners Genentech in RNAi Global Licensing Collaboration

    Details:

    Through the licensing deal, an undisclosed oligonucleotide product will be utilized to address obesity, aiming to advance treatment options.


    Lead Product(s): Undisclosed

    Therapeutic Area: Nutrition and Weight Loss Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Oligonucleotide

    Recipient: Sanegene Bio

    Deal Size: $1,700.0 million Upfront Cash: $200.0 million

    Deal Type: Licensing Agreement February 02, 2026

    blank

    05

    Genentech

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Genentech

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Nutrition and Weight Loss

    Highest Development Status : Undisclosed

    Recipient : Sanegene Bio

    Deal Size : $1,700.0 million

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    SanegeneBio Partners Genentech in RNAi Global Licensing Collaboration

    Details : Through the licensing deal, an undisclosed oligonucleotide product will be utilized to address obesity, aiming to advance treatment options.

    Product Name : Undisclosed

    Product Type : Oligonucleotide

    Upfront Cash : $200.0 million

    February 02, 2026

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

    Details:

    Inavolisib is a small molecule drug, which is currently being evaluated in Phase II clinical studies for the treatment of breast neoplasms.


    Lead Product(s): Inavolisib,Fulvestrant

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable January 27, 2026

    blank

    06

    F. Hoffmann-La Roche

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    F. Hoffmann-La Roche

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Inavolisib,Fulvestrant

    Therapeutic Area : Oncology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Canc...

    Details : Inavolisib is a small molecule drug, which is currently being evaluated in Phase II clinical studies for the treatment of breast neoplasms.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    January 27, 2026

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight Without Type 2 Diabetes

    Details:

    RG6640 (RO7795068) is a peptide drug, which is currently being evaluated in Phase III clinical studies for the treatment of obesity.


    Lead Product(s): RO7795068

    Therapeutic Area: Nutrition and Weight Loss Brand Name: RG6640

    Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable January 20, 2026

    blank

    07

    F. Hoffmann-La Roche

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    F. Hoffmann-La Roche

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : RO7795068

    Therapeutic Area : Nutrition and Weight Loss

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight W...

    Details : RG6640 (RO7795068) is a peptide drug, which is currently being evaluated in Phase III clinical studies for the treatment of obesity.

    Product Name : RG6640

    Product Type : Peptide, Unconjugated

    Upfront Cash : Inapplicable

    January 20, 2026

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes

    Details:

    RG6640 (RO7795068) is a peptide drug, which is currently being evaluated in Phase III clinical studies for the treatment of obesity.


    Lead Product(s): RO7795068

    Therapeutic Area: Nutrition and Weight Loss Brand Name: RG6640

    Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable January 20, 2026

    blank

    08

    F. Hoffmann-La Roche

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    F. Hoffmann-La Roche

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : RO7795068

    Therapeutic Area : Nutrition and Weight Loss

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight a...

    Details : RG6640 (RO7795068) is a peptide drug, which is currently being evaluated in Phase III clinical studies for the treatment of obesity.

    Product Name : RG6640

    Product Type : Peptide, Unconjugated

    Upfront Cash : Inapplicable

    January 20, 2026

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Dose-Escalation Study of RO7875913 in Healthy Participants

    Details:

    (RO7875913) is currently being evaluated in Phase I clinical studies for the treatment of undisclosed medical condition.


    Lead Product(s): RO7875913

    Therapeutic Area: Undisclosed Brand Name: Undisclosed

    Study Phase: Phase IProduct Type: Undisclosed

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable January 15, 2026

    blank

    09

    Genentech

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Genentech

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : RO7875913

    Therapeutic Area : Undisclosed

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Dose-Escalation Study of RO7875913 in Healthy Participants

    Details : (RO7875913) is currently being evaluated in Phase I clinical studies for the treatment of undisclosed medical condition.

    Product Name : Undisclosed

    Product Type : Undisclosed

    Upfront Cash : Inapplicable

    January 15, 2026

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Study to Evaluate the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of ZN-A-1041 in Healthy Participants

    Details:

    Perzebertinib is a Small Molecule drug, which is currently being evaluated in Phase I clinical studies for the treatment of undefined medical condition.


    Lead Product(s): Perzebertinib,Rabeprazole Sodium

    Therapeutic Area: Undisclosed Brand Name: Undisclosed

    Study Phase: Phase IProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable January 09, 2026

    blank

    10

    Genentech

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Genentech

    U.S.A
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Perzebertinib,Rabeprazole Sodium

    Therapeutic Area : Undisclosed

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Study to Evaluate the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of ZN-A-1...

    Details : Perzebertinib is a Small Molecule drug, which is currently being evaluated in Phase I clinical studies for the treatment of undefined medical condition.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    January 09, 2026

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    01

    Brand Name : KADCYLA

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : KADCYLA

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    ADO-TRASTUZUMAB EMTANSINE

    Genentech

    Dosage Form : VIAL; SINGLE-USE

    Proprietary Name : KADCYLA

    Dosage Strength : 100MG

    Approval Date :

    Application Number : 125427

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : KADCYLA

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : KADCYLA

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    ADO-TRASTUZUMAB EMTANSINE

    Genentech

    Dosage Form : VIAL; SINGLE-USE

    Proprietary Name : KADCYLA

    Dosage Strength : 160MG

    Approval Date :

    Application Number : 125427

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : ALECENSA

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : ALECENSA

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : Yes

    TE Code :

    ALECTINIB HYDROCHLORIDE

    F. Hoffmann-La Roche

    Dosage Form : CAPSULE; ORAL

    Proprietary Name : ALECENSA

    Dosage Strength : EQ 150MG BASE

    Approval Date : 2015-12-11

    Application Number : 208434

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : ACTIVASE

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : ACTIVASE

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    ALTEPLASE

    Genentech

    Dosage Form : VIAL; SINGLE-USE

    Proprietary Name : ACTIVASE

    Dosage Strength : 100MG/VIAL

    Approval Date :

    Application Number : 103172

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : ACTIVASE

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : ACTIVASE

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    ALTEPLASE

    Genentech

    Dosage Form : VIAL; SINGLE-USE

    Proprietary Name : ACTIVASE

    Dosage Strength : 50MG/VIAL

    Approval Date :

    Application Number : 103172

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : CATHFLO ACTIVASE

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : CATHFLO ACTIVASE

    U.S.A
    International Sweetener Colloquium
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    ALTEPLASE

    Genentech

    Dosage Form : VIAL

    Proprietary Name : CATHFLO ACTIVASE

    Dosage Strength : 2MG/VIAL

    Approval Date :

    Application Number : 103172

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : COACTIN

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : COACTIN

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code :

    AMDINOCILLIN

    F. Hoffmann-La Roche

    Dosage Form : INJECTABLE; INJECTION

    Proprietary Name : COACTIN

    Dosage Strength : 250MG/VIAL

    Approval Date : 1984-12-21

    Application Number : 50565

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : COACTIN

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : COACTIN

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code :

    AMDINOCILLIN

    F. Hoffmann-La Roche

    Dosage Form : INJECTABLE; INJECTION

    Proprietary Name : COACTIN

    Dosage Strength : 500MG/VIAL

    Approval Date : 1984-12-21

    Application Number : 50565

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : COACTIN

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : COACTIN

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code :

    AMDINOCILLIN

    F. Hoffmann-La Roche

    Dosage Form : INJECTABLE; INJECTION

    Proprietary Name : COACTIN

    Dosage Strength : 1GM/VIAL

    Approval Date : 1984-12-21

    Application Number : 50565

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : ENDEP

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : ENDEP

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code :

    AMITRIPTYLINE HYDROCHLORIDE

    F. Hoffmann-La Roche

    Dosage Form : TABLET; ORAL

    Proprietary Name : ENDEP

    Dosage Strength : 150MG

    Approval Date : 1982-01-01

    Application Number : 85303

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Europe

    read-more
    read-more

    01

    Brand Name : Vabysmo

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Vabysmo

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Allowed

    Registration Country : Switzerland

    Faricimab

    F. Hoffmann-La Roche

    Dosage Form : Solution For Injection

    Dosage Strength : 6mg/0.05ml

    Packaging :

    Brand Name : Vabysmo

    Approval Date : 25/05/2022

    Application Number : 68395

    Regulatory Info : Allowed

    Registration Country : Switzerland

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : Vabysmo

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Vabysmo

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Allowed

    Registration Country : Switzerland

    Faricimab

    F. Hoffmann-La Roche

    Dosage Form : Solution For Injection

    Dosage Strength : 6mg/0.05ml

    Packaging :

    Brand Name : Vabysmo

    Approval Date : 04/12/2024

    Application Number : 69709

    Regulatory Info : Allowed

    Registration Country : Switzerland

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : Vabysmo

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Vabysmo

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Approved

    Registration Country : Sweden

    Faricimab

    F. Hoffmann-La Roche

    Dosage Form : Injectable Solution

    Dosage Strength : 120mg/ml

    Packaging :

    Brand Name : Vabysmo

    Approval Date : 15-09-2022

    Application Number : 2.02E+13

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : Vabysmo

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Vabysmo

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Approved

    Registration Country : Sweden

    Faricimab

    F. Hoffmann-La Roche

    Dosage Form : Solution For Injection

    Dosage Strength : 120mg/ml

    Packaging :

    Brand Name : Vabysmo

    Approval Date : 12-12-2024

    Application Number : 2.02E+13

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : Enspryng

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Enspryng

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Allowed

    Registration Country : Switzerland

    Satralizumab

    F. Hoffmann-La Roche

    Dosage Form : Solution For Injection

    Dosage Strength : 120mg/ml

    Packaging :

    Brand Name : Enspryng

    Approval Date : 13/07/2020

    Application Number : 67617

    Regulatory Info : Allowed

    Registration Country : Switzerland

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : Enspryng

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Enspryng

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Approved

    Registration Country : Sweden

    Satralizumab

    F. Hoffmann-La Roche

    Dosage Form : Solution For Injection

    Dosage Strength : 120mg

    Packaging :

    Brand Name : Enspryng

    Approval Date : 24-06-2021

    Application Number : 2.02E+13

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : Alecensa

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Alecensa

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Allowed

    Registration Country : Switzerland

    Alectinib

    F. Hoffmann-La Roche

    Dosage Form : Hard Capsule

    Dosage Strength : 150mg

    Packaging :

    Brand Name : Alecensa

    Approval Date : 26/01/2017

    Application Number : 65970

    Regulatory Info : Allowed

    Registration Country : Switzerland

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : Alecensa

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Alecensa

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Prescription

    Registration Country : Estonia

    Alectinib

    F. Hoffmann-La Roche

    Dosage Form : Capsule

    Dosage Strength : 150mg

    Packaging :

    Brand Name : Alecensa

    Approval Date :

    Application Number :

    Regulatory Info : Prescription

    Registration Country : Estonia

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : Alecensa

    Germany
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Alecensa

    Germany
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorized

    Registration Country : Spain

    Alectinib Hydrochloride

    Roche Diagnostics GmbH

    Dosage Form : Hard Capsule

    Dosage Strength : 150MG

    Packaging :

    Brand Name : Alecensa

    Approval Date : 06-03-2017

    Application Number : 1161169001

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : Alecensa

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Alecensa

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorized

    Registration Country : Spain

    Alectinib Hydrochloride

    F. Hoffmann-La Roche

    Dosage Form : Hard Capsule

    Dosage Strength : 150MG

    Packaging :

    Brand Name : Alecensa

    Approval Date : 29-08-2025

    Application Number : 1161169001IP

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Canada

    read-more
    read-more

    01

    Brand Name : ALECENSARO

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : ALECENSARO

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Prescription

    Registration Country : Canada

    ALECTINIB (ALECTINIB HYDROCHLORIDE)

    F. Hoffmann-La Roche

    Dosage Form : CAPSULE

    Dosage Strength : 150MG

    Packaging : 240

    Brand Name : ALECENSARO

    Approval Date :

    Application Number : 2458136

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : ACTIVASE RT-PA

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : ACTIVASE RT-PA

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Prescription

    Registration Country : Canada

    ALTEPLASE

    F. Hoffmann-La Roche

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 100MG/KIT

    Packaging : 100 ML

    Brand Name : ACTIVASE RT-PA

    Approval Date :

    Application Number : 2147440

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : ACTIVASE RT-PA

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : ACTIVASE RT-PA

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Schedule D

    Registration Country : Canada

    ALTEPLASE

    F. Hoffmann-La Roche

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 50MG/KIT

    Packaging : 100 ML

    Brand Name : ACTIVASE RT-PA

    Approval Date :

    Application Number : 2225689

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : CATHFLO

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : CATHFLO

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Schedule D

    Registration Country : Canada

    ALTEPLASE

    F. Hoffmann-La Roche

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 2MG/VIAL

    Packaging : 2.2 ML

    Brand Name : CATHFLO

    Approval Date :

    Application Number : 2245859

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : TECENTRIQ

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : TECENTRIQ

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Schedule D

    Registration Country : Canada

    ATEZOLIZUMAB

    F. Hoffmann-La Roche

    Dosage Form : SOLUTION

    Dosage Strength : 1200MG/20ML

    Packaging : 20ML

    Brand Name : TECENTRIQ

    Approval Date :

    Application Number : 2462990

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : TECENTRIQ

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : TECENTRIQ

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Prescription

    Registration Country : Canada

    ATEZOLIZUMAB

    F. Hoffmann-La Roche

    Dosage Form : SOLUTION

    Dosage Strength : 840MG/14ML

    Packaging :

    Brand Name : TECENTRIQ

    Approval Date :

    Application Number : 2492393

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : TECENTRIQ SC

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : TECENTRIQ SC

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Schedule D

    Registration Country : Canada

    ATEZOLIZUMAB

    F. Hoffmann-La Roche

    Dosage Form : SOLUTION

    Dosage Strength : 125MG/ML

    Packaging :

    Brand Name : TECENTRIQ SC

    Approval Date :

    Application Number : 2546310

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : XOFLUZA

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : XOFLUZA

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Prescription

    Registration Country : Canada

    BALOXAVIR MARBOXIL

    F. Hoffmann-La Roche

    Dosage Form : TABLET

    Dosage Strength : 20MG

    Packaging :

    Brand Name : XOFLUZA

    Approval Date :

    Application Number : 2496364

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : XOFLUZA

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : XOFLUZA

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Prescription

    Registration Country : Canada

    BALOXAVIR MARBOXIL

    F. Hoffmann-La Roche

    Dosage Form : TABLET

    Dosage Strength : 80MG

    Packaging :

    Brand Name : XOFLUZA

    Approval Date :

    Application Number : 2524163

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : PROLOPA CAP 100-25

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : PROLOPA CAP 100-25

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Prescription

    Registration Country : Canada

    BENSERAZIDE (BENSERAZIDE HYDROCHLORIDE)

    F. Hoffmann-La Roche

    Dosage Form : CAPSULE

    Dosage Strength : 25MG

    Packaging : 100

    Brand Name : PROLOPA CAP 100-25

    Approval Date :

    Application Number : 386464

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Australia

    read-more
    read-more

    01

    Brand Name : Alecensa

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Alecensa

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Australia

    Alectinib

    F. Hoffmann-La Roche

    Dosage Form :

    Dosage Strength :

    Packaging : 224

    Brand Name : Alecensa

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Australia

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : Tecentriq

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Tecentriq

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Australia

    Atezolizumab

    F. Hoffmann-La Roche

    Dosage Form :

    Dosage Strength :

    Packaging : 1

    Brand Name : Tecentriq

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Australia

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : Tecentriq

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Tecentriq

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Australia

    Atezolizumab

    F. Hoffmann-La Roche

    Dosage Form :

    Dosage Strength :

    Packaging : 1

    Brand Name : Tecentriq

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Australia

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : Tecentriq

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Tecentriq

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Australia

    Atezolizumab

    F. Hoffmann-La Roche

    Dosage Form :

    Dosage Strength :

    Packaging : 1

    Brand Name : Tecentriq

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Australia

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : Tecentriq

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Tecentriq

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Australia

    Atezolizumab

    F. Hoffmann-La Roche

    Dosage Form :

    Dosage Strength :

    Packaging : 1

    Brand Name : Tecentriq

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Australia

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : Tecentriq

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Tecentriq

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Australia

    Atezolizumab

    F. Hoffmann-La Roche

    Dosage Form :

    Dosage Strength :

    Packaging : 1

    Brand Name : Tecentriq

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Australia

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : Tecentriq

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Tecentriq

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Australia

    Atezolizumab

    F. Hoffmann-La Roche

    Dosage Form :

    Dosage Strength :

    Packaging : 1

    Brand Name : Tecentriq

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Australia

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : Tecentriq

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Tecentriq

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Australia

    Atezolizumab

    F. Hoffmann-La Roche

    Dosage Form :

    Dosage Strength :

    Packaging : 1

    Brand Name : Tecentriq

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Australia

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : Tecentriq

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Tecentriq

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Australia

    Atezolizumab

    F. Hoffmann-La Roche

    Dosage Form :

    Dosage Strength :

    Packaging : 1

    Brand Name : Tecentriq

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Australia

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : Tecentriq

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Tecentriq

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Australia

    Atezolizumab

    F. Hoffmann-La Roche

    Dosage Form :

    Dosage Strength :

    Packaging : 1

    Brand Name : Tecentriq

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Australia

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    South Africa

    read-more
    read-more

    01

    Brand Name : Alecensa

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Alecensa

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Originator

    Registration Country : South Africa

    Alectinib

    F. Hoffmann-La Roche

    Dosage Form : CAPS

    Dosage Strength : 150MG

    Packaging : 224X1MG

    Brand Name : Alecensa

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : TECENTRIQ 840 MG

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : TECENTRIQ 840 MG

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Originator

    Registration Country : South Africa

    Atezolizumab

    F. Hoffmann-La Roche

    Dosage Form : INF

    Dosage Strength : 840mg

    Packaging : 14X1mg

    Brand Name : TECENTRIQ 840 MG

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : TECENTRIQ 1 200 MG

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : TECENTRIQ 1 200 MG

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Originator

    Registration Country : South Africa

    Atezolizumab

    F. Hoffmann-La Roche

    Dosage Form : INF

    Dosage Strength : 1200mg

    Packaging : 20X1mg

    Brand Name : TECENTRIQ 1 200 MG

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : Madopar

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Madopar

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Originator

    Registration Country : South Africa

    Benserazide

    F. Hoffmann-La Roche

    Dosage Form : TAB

    Dosage Strength : 50mg

    Packaging : 100X1mg

    Brand Name : Madopar

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : Madopar Hbs

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Madopar Hbs

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Originator

    Registration Country : South Africa

    Benserazide

    F. Hoffmann-La Roche

    Dosage Form : CAP

    Dosage Strength : 25mg

    Packaging : 100X1mg

    Brand Name : Madopar Hbs

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : Aaa Throat Spray

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Aaa Throat Spray

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Originator

    Registration Country : South Africa

    Benzocaine

    F. Hoffmann-La Roche

    Dosage Form : SPR

    Dosage Strength : 10mg/ml

    Packaging : 50X1mg/ml

    Brand Name : Aaa Throat Spray

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : Avastin 400

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Avastin 400

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Originator

    Registration Country : South Africa

    Bevacizumab

    F. Hoffmann-La Roche

    Dosage Form : INF

    Dosage Strength : 400mg/16ml

    Packaging : 16X1mg/16ml

    Brand Name : Avastin 400

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : Avastin 100

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Avastin 100

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Originator

    Registration Country : South Africa

    Bevacizumab

    F. Hoffmann-La Roche

    Dosage Form : INF

    Dosage Strength : 100mg/4ml

    Packaging : 4X1mg/4ml

    Brand Name : Avastin 100

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : Lexotan

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Lexotan

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Originator

    Registration Country : South Africa

    Bromazepam

    F. Hoffmann-La Roche

    Dosage Form : TAB

    Dosage Strength : 3mg

    Packaging : 90X1mg

    Brand Name : Lexotan

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : Lexotan

    Switzerland
    International Sweetener Colloquium
    Not Confirmed
    arrow

    Brand Name : Lexotan

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Originator

    Registration Country : South Africa

    Bromazepam

    F. Hoffmann-La Roche

    Dosage Form : TAB

    Dosage Strength : 6mg

    Packaging : 90X1mg

    Brand Name : Lexotan

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Upload your portfolio for free, ask us

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    EDQM

    read-more
    read-more

    01

    GMP Certified

    EU
    International Sweetener Colloquium
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Genentech

    Type : GMP Certificates

    Number : NL/H 14/100...

    EudraGMDP Key : 24418

    Country : U.S.A

    Issue Date :

    Post Code : OR 97124

    NCA Ref : 2.4418139626...

    City : Hillsboro

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    GMP Certified

    EU
    International Sweetener Colloquium
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Genentech

    Type : GMP Certificates

    Number : DK H 000231...

    EudraGMDP Key : 12056

    Country : U.S.A

    Issue Date :

    Post Code : CA 95688

    NCA Ref : 253078

    City : Vacaville

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    GMP Certified

    EU
    International Sweetener Colloquium
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Genentech

    Type : GMP Certificates

    Number : DK H 000231...

    EudraGMDP Key : 12056

    Country : U.S.A

    Issue Date :

    Post Code : CA 95688

    NCA Ref : 253078

    City : Vacaville

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Roche and get a quotation

    Roche is a supplier offers 103 products (APIs, Excipients or Intermediates).

    Find a price of Ceftriaxone bulk with CEP offered by Roche

    Find a price of Vitamin D3 bulk with JDMF offered by Roche

    Find a price of Bezafibrate bulk with CEP offered by Roche

    Find a price of Carvedilol bulk with CEP offered by Roche

    Find a price of Dextromethorphan Hydrobromide bulk with JDMF offered by Roche

    Find a price of Sulfadoxine bulk with CEP offered by Roche

    Find a price of Torsemide bulk with CEP offered by Roche

    Find a price of MSBA30K PEG REAGENT FOR MIRCERA (RO0503819) bulk with DMF offered by Roche

    Find a price of Acetazolamide bulk offered by Roche

    Find a price of Adenosine bulk offered by Roche

    Find a price of Altretamine bulk offered by Roche

    Find a price of Amitriptyline Hydrochloride bulk offered by Roche

    Find a price of Atropine Sulfate bulk offered by Roche

    Find a price of Beta Carotene bulk offered by Roche

    Find a price of Biotin bulk offered by Roche

    Find a price of Brompheniramine Maleate bulk offered by Roche

    Find a price of Butoconazole Nitrate bulk offered by Roche

    Find a price of Calcitriol bulk offered by Roche

    Find a price of Captopril bulk offered by Roche

    Find a price of Cetirizine Dihydrochloride bulk offered by Roche

    Find a price of Chenodeoxycholic Acid bulk offered by Roche

    Find a price of Chlordiazepoxide bulk offered by Roche

    Find a price of Chlorpheniramine Maleate bulk offered by Roche

    Find a price of Clonidine bulk offered by Roche

    Find a price of Debrisoquin bulk offered by Roche

    Find a price of Diphenhydramine Hydrochloride bulk offered by Roche

    Find a price of Disopyramide bulk offered by Roche

    Find a price of Doxylamine Succinate bulk offered by Roche

    Find a price of Etidronic Acid bulk offered by Roche

    Find a price of Ferrous Fumarate bulk offered by Roche

    Find a price of Fluocytosine bulk offered by Roche

    Find a price of Flurbiprofen bulk offered by Roche

    Find a price of Glibenclamide bulk offered by Roche

    Find a price of Heparin Sodium bulk offered by Roche

    Find a price of Human Epidermal Growth Factor bulk offered by Roche

    Find a price of Hydrocortisone Acetate bulk offered by Roche

    Find a price of Ibuprofen bulk offered by Roche

    Find a price of Isotretinoin bulk offered by Roche

    Find a price of Ketoprofen bulk offered by Roche

    Find a price of Levodopa bulk offered by Roche

    Find a price of Levorphanol Tartrate bulk offered by Roche

    Find a price of Meclizine Hydrochloride bulk offered by Roche

    Find a price of Meprobamate bulk offered by Roche

    Find a price of Methyl Testosterone bulk offered by Roche

    Find a price of Miconazole bulk offered by Roche

    Find a price of Neostigmine Methylsulfate bulk offered by Roche

    Find a price of Niacin bulk offered by Roche

    Find a price of Nufenoxole bulk offered by Roche

    Find a price of Phendimetrazine Tartrate bulk offered by Roche

    Find a price of Phenobarbital bulk offered by Roche

    Find a price of Phenylephrine Hydrochloride bulk offered by Roche

    Find a price of Phenylpropanolamine Hydrochloride bulk offered by Roche

    Find a price of Potassium Chloride bulk offered by Roche

    Find a price of Procarbazine Hydrochloride bulk offered by Roche

    Find a price of Pseudoephedrine Hydrochloride bulk offered by Roche

    Find a price of Pyridostigmine bulk offered by Roche

    Find a price of Pyridoxal Phosphate bulk offered by Roche

    Find a price of Riboflavin 5 Phosphate Sodium bulk offered by Roche

    Find a price of Sulfadimethoxine bulk offered by Roche

    Find a price of Tetrabenazine bulk offered by Roche

    Find a price of Theophylline bulk offered by Roche

    Find a price of Thiphenamil bulk offered by Roche

    Find a price of Thyrotropin-Releasing Hormone bulk offered by Roche

    Find a price of Ticlopidine bulk offered by Roche

    Find a price of Tretinoin bulk offered by Roche

    Find a price of Tromethamine API bulk offered by Roche

    Find a price of Ursodeoxycholic Acid bulk offered by Roche

    Find a price of Vitamin D3 bulk offered by Roche

    Find a price of Zalcitabine bulk offered by Roche

    Find a price of FACILITIES UTILIZED IN DALRY, SCOTLAND bulk offered by Roche

    Find a price of RO 20 5933 bulk offered by Roche

    Find a price of NOLAMINE REPEAT ACTION TABLETS bulk offered by Roche

    Find a price of L bulk offered by Roche

    Find a price of PSEUDOEPHEDRINE HCL & CHLORPHENIRAMINE MALEATE S.R.C. bulk offered by Roche

    Find a price of INTERLEUKIN-2 (HUMAN, RECOMBINANT, E. COLI, HOFFMAN-LA ROCHE) bulk offered by Roche

    Find a price of FACILITIES AND OPERATING PROCEDURES IN SAO PAULO, BRAZIL bulk offered by Roche

    Find a price of MEDIGESIC PLUS CAPS bulk offered by Roche

    Find a price of THEOBID & THEOBID JR. S.R. CAPS 130MG & 260MG bulk offered by Roche

    Find a price of ACTIFED SUSTAINED RELEASE CAPSULES bulk offered by Roche

    Find a price of ANTIPRESS TAB bulk offered by Roche

    Find a price of MANUFACTURING FACILITIES AND CONTROLS bulk offered by Roche

    Find a price of ORTHO-NOVUM 1/5OE21 bulk offered by Roche

    Find a price of FLUOROLACTAM bulk offered by Roche

    Find a price of RO 5-9963 (DESMETHYLMISON IDAZOLE bulk offered by Roche

    Find a price of RO 3-1428 (5,8,LL,L4-EICOSATETRAYNOIC ACID) bulk offered by Roche

    Find a price of HYBEPHEN -LA CAPSULES bulk offered by Roche

    Find a price of FACILITIES CONTROL PERSONNEL bulk offered by Roche

    Find a price of B-AMINOPROPIONITRILE FUMARATE bulk offered by Roche

    Find a price of PROTAMINE HCL, RO 6-1588/1 bulk offered by Roche

    Find a price of Entrectinib bulk offered by Roche

    Find a price of Erlotinib Hydrochloride bulk offered by Roche

    Find a price of Flumazenil bulk offered by Roche

    Find a price of Ganciclovir bulk offered by Roche

    Find a price of Granisetron bulk offered by Roche

    Find a price of Ibandronate Sodium bulk offered by Roche

    Find a price of Ketorolac Trometamol bulk offered by Roche

    Find a price of Oseltamivir Phosphate bulk offered by Roche

    Find a price of MANUFACTURING OPERATIONS bulk offered by Roche

    Find a price of Inaboliship bulk offered by Roche

    Find a price of SPECIFICATIONS & DIRECTIONS FOR TESTING RAW MATERI bulk offered by Roche

    Find a price of ADITOPRIM bulk offered by Roche

    Find a price of PACKAGING MATERIALS bulk offered by Roche

    Find a price of CARBAZOLE ESTER bulk offered by Roche

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search